rs34084388

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001130438.3(SPTAN1):​c.2343C>A​(p.Ala781Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00561 in 1,614,036 control chromosomes in the GnomAD database, including 392 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. A781A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.029 ( 197 hom., cov: 32)
Exomes 𝑓: 0.0032 ( 195 hom. )

Consequence

SPTAN1
NM_001130438.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -4.01

Publications

2 publications found
Variant links:
Genes affected
SPTAN1 (HGNC:11273): (spectrin alpha, non-erythrocytic 1) Spectrins are a family of filamentous cytoskeletal proteins that function as essential scaffold proteins that stabilize the plasma membrane and organize intracellular organelles. Spectrins are composed of alpha and beta dimers that associate to form tetramers linked in a head-to-head arrangement. This gene encodes an alpha spectrin that is specifically expressed in nonerythrocytic cells. The encoded protein has been implicated in other cellular functions including DNA repair and cell cycle regulation. Mutations in this gene are the cause of early infantile epileptic encephalopathy-5. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010]
SPTAN1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P, Ambry Genetics
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neuronopathy, distal hereditary motor, autosomal dominant 11
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • spastic paraplegia 91, autosomal dominant, with or without cerebellar ataxia
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spastic paraplegia
    Inheritance: AR Classification: LIMITED Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 9-128584431-C-A is Benign according to our data. Variant chr9-128584431-C-A is described in ClinVar as Benign. ClinVar VariationId is 139277.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0983 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001130438.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTAN1
NM_001130438.3
MANE Select
c.2343C>Ap.Ala781Ala
synonymous
Exon 17 of 57NP_001123910.1Q13813-2
SPTAN1
NM_001375318.1
c.2379C>Ap.Ala793Ala
synonymous
Exon 18 of 59NP_001362247.1
SPTAN1
NM_001375310.1
c.2343C>Ap.Ala781Ala
synonymous
Exon 17 of 58NP_001362239.1A0A994J6W3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SPTAN1
ENST00000372739.7
TSL:1 MANE Select
c.2343C>Ap.Ala781Ala
synonymous
Exon 17 of 57ENSP00000361824.4Q13813-2
SPTAN1
ENST00000372731.8
TSL:1
c.2343C>Ap.Ala781Ala
synonymous
Exon 17 of 56ENSP00000361816.4Q13813-1
SPTAN1
ENST00000358161.9
TSL:1
c.2343C>Ap.Ala781Ala
synonymous
Exon 17 of 55ENSP00000350882.6Q13813-3

Frequencies

GnomAD3 genomes
AF:
0.0289
AC:
4401
AN:
152054
Hom.:
195
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0100
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000632
Gnomad OTH
AF:
0.0177
GnomAD2 exomes
AF:
0.00756
AC:
1897
AN:
250904
AF XY:
0.00563
show subpopulations
Gnomad AFR exome
AF:
0.103
Gnomad AMR exome
AF:
0.00440
Gnomad ASJ exome
AF:
0.0000994
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000406
Gnomad OTH exome
AF:
0.00506
GnomAD4 exome
AF:
0.00317
AC:
4631
AN:
1461864
Hom.:
195
Cov.:
37
AF XY:
0.00273
AC XY:
1986
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.106
AC:
3557
AN:
33478
American (AMR)
AF:
0.00499
AC:
223
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.000313
AC:
27
AN:
86254
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53410
Middle Eastern (MID)
AF:
0.00885
AC:
51
AN:
5764
European-Non Finnish (NFE)
AF:
0.000319
AC:
355
AN:
1112006
Other (OTH)
AF:
0.00690
AC:
417
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
276
553
829
1106
1382
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0291
AC:
4424
AN:
152172
Hom.:
197
Cov.:
32
AF XY:
0.0288
AC XY:
2144
AN XY:
74384
show subpopulations
African (AFR)
AF:
0.101
AC:
4186
AN:
41500
American (AMR)
AF:
0.0100
AC:
153
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4814
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000632
AC:
43
AN:
68002
Other (OTH)
AF:
0.0175
AC:
37
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
213
426
639
852
1065
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0105
Hom.:
31
Bravo
AF:
0.0337
Asia WGS
AF:
0.0110
AC:
37
AN:
3478
EpiCase
AF:
0.000545
EpiControl
AF:
0.000830

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
Developmental and epileptic encephalopathy (1)
-
-
1
Developmental and epileptic encephalopathy, 5 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
0.39
DANN
Benign
0.68
PhyloP100
-4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=81/19
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34084388; hg19: chr9-131346710; API